Page last updated: 2024-08-17

bromodeoxyuridine and Carcinoma, Acinar Cell

bromodeoxyuridine has been researched along with Carcinoma, Acinar Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bierkamp, C; Clerc, P; Dufresne, M; Fourmy, D; Lulka, H; Mathieu, A; Portolan, G; Pradayrol, L; Seva, C	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Carcinoma, Acinar Cell

Article	Year
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation. International journal of cancer, 2005, May-20, Volume: 115, Issue:1 Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes	2005

Article

Year

Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.

International journal of cancer, 2005, May-20, Volume: 115, Issue:1

Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes

2005